Fertility Centers of Illinois is home to two the world’s most advanced IVF laboratories and is often called on by pharmaceuticals companies to participate in research projects.
Fertility Centers of Illinois’ clinical research team is dedicated to further pursuing advancements in fertility technology in order to provide our patients with the most recent, most proven treatment options by participating in clinical trials and research studies. Our team of revered experts regularly contributes to many leading peer-reviewed fertility journals.
We participate in many studies, both large and small. You will find the large studies posted here on our site and you are encouraged to fill out the requested forms.
We also periodically conduct small scale research projects aimed at specific populations. Due to the size of these studies, we don’t advertise enrollment for the trials. If you would like to inquire about availability of any research opportunities, please email FCIResearch@Integramed.com.
Fertility Centers of Illinois conducts ground-breaking research that has contributed to improvements in assisted reproductive technologies and fertility treatment. Patients at Fertility Centers of Illinois benefit from working with the experts who conducted these studies; when appropriate, patients are invited to participate in research studies.
Please check back for open study enrollment
RITA Study – CLOSED FOR ENROLLMENT
Fertility Centers of Illinois is seeking women between the ages 18-42 with a documented history of infertility to participate in a new IVF/ICSI clinical research trial. Study subjects who meet the study entry criteria may receive the IVF/ICSI cycle and associated study medications.
You may be eligible to participate if you have:
• Documented history of infertility, or a partner diagnosed with male factor infertility
• A body mass Index under 38 kg/m2 inclusive at the time of screening
• Regular menstrual cycles between 24-35 days inclusive
• Normal ovarian testing, FSH 1 – 15 IU/L
• Documentation of normal PAP smear, TSH, Prolactin
• Documentation of a normal uterine cavity
• No more than one previous completed IVF/ICSI cycle
• No more than two previous consecutive miscarriages
Stress and Male Fertility – CLOSED FOR ENROLLMENT
FCI has been offered an exciting opportunity to see if a new mobile phone app can help lower the distress levels of men who are experiencing infertility. The app is designed to provide support and coping solutions for men experiencing infertility, or men whose partner is experiencing infertility. The app contains numerous suggestions for the man himself, as well as a variety of ideas to help him provide more emotional support for his partner.
Participation in this study is simple. You don’t need to come into the clinic for any extra visits; the whole study can be done from home. You would be asked to complete some forms online when you start the study, and again 30 days later. Completion of the forms takes less than 30 minutes. All participants will receive the app for free – either when you enter the study or 30 days later. All collected information is anonymous and your medical team would not know if you were a part of the study or not. Each participant will receive a $25 Amazon gift card after the second set of forms is completed.
Hormonal Regulation of Granulosa Cell Function – CLOSED FOR ENROLLMENT
FCI is collaborating on a research project with Dr. Carlos Stocco, senior scientist at University of Illinois-Chicago, to determine the function of the cumulus cells (nurse cells that surround the egg).
During an egg retrieval, the follicular fluid is aspirated and the egg is then identified by an embryologist from this fluid. When the egg is aspirated it comes in a cumulus oocyte complex (egg surrounded by nurse cells). These nurse cells are removed and fertilization is performed. Typically these nurse cells are discarded. This study is using otherwise discarded materials to learn about these nurse cells to ultimately learn more about egg function. FCI is proud to be a part of research helping to discover tomorrows fertility treatments.
Joint Research Study To Find Out Whether Yoga Can Help Your Fertility – CLOSED FOR ENROLLMENT
Fertility Centers of Illinois and Pulling Down the Moon are conducting a joint research study to learn whether yoga has an impact on anxiety levels and pregnancy outcomes in women going through medicated fertility cycles. The Lead Investigators on this study are Jennifer Hirshfeld-Cytron, M.D. of Fertility Centers of Illinois and Beth Heller, M.S. of Pulling Down the Moon.
You are eligible to participate in this study if you are:
- A female patient of Fertility Centers of Illinois
- You recently completed an unsuccessful ART cycle (or successful cycle that ended with miscarriage)
- You are planning a subsequent, non-donor ART cycle within six months
Study participants will attend one of three intervention groups and complete a pre and post-test anxiety inventory questionnaire. Participants will be eligible to take classes for half-price, and will also receive free study materials valued up to $35.
- A six-week Yoga for Fertility program
- A six-week web-based Yoga for Fertility program with at-home, DVD based yoga practice
- A six-week discussion-only Mind/Body Strategies for Fertility class
Yoga and Discussion-only classes will be held in Chicago – River North and Highland Park.
For more information, please contact firstname.lastname@example.org.
Joint Research Study to Understand Women’s Motivation for Fertility Screening – CLOSED FOR ENROLLMENT
Researchers at Northwestern University are conducting a study in partnership with Fertility Centers of Illinois to learn more about the experience of patients seeking Fertility Awareness Checkups. If you or a woman you know is considering a Fertility Awareness Checkup, has had a check up in the past, or is in the process of doing a Fertility Awareness Checkup, we would be interested in speaking with you!
You are eligible to participate in this study if you are:
- A woman between the ages of 18-40.
- Interested in undergoing a Fertility Awareness Checkup, are in the process of undergoing a Fertility Awareness Checkup, or have had a Fertility Awareness Checkup through Fertility Centers of Illinois in the past.
Study participants will be asked to complete a 30 minute-1 hour in-person interview with a researcher about their experiences with planning to undergo or completing a Fertility Awareness Checkup. Participants will also be asked if a researcher can accompany them to a follow up visit. This is an optional part of the study and is entirely voluntary. Eligible participants who complete interviews will be provided a $25 Amazon gift card for their time. Some participants may be asked to complete a follow up interviews and will receive a second $25 Amazon gift card.
Participants seeking care at any Fertility Center of Illinois location are welcome to participate.
For more information, please email: email@example.com or call (803) 409-8786.
Supported by Fertility Centers of Illinois and Northwestern University
Northwestern IRB STU00205769
Principal Investigator: Dr. Thomas McDade, PhD
Controlled Ovarian Stimulation (COS) Research Study – CLOSED FOR ENROLLMENT
Fertility Centers of Illinois is currently seeking patients to participate in a fertility research study designed to compare two medications used for controlled ovarian stimulation (COS), in In Vitro Fertilization (IVF) cycles.
You may be eligible for the study if you:
- Are between 21 to 35 years old
- Have a regular menstrual cycle of 21 to 45 days
- Have a history of infertility and desire pregnancy
- Have an AMH (Anti-Mullerian Hormone) ≥ 5 (ng/mL)
The study medications and some study-related tests and procedures may be provided at no cost to qualified participants.
LutrePulse Clinical Research Study – CLOSED FOR ENROLLMENT
Fertility Centers of Illinois is participating in the LutrePulse Clinical Research Study for women between the ages of 18-40 who have been diagnosed with primary amenorrhea with hypogonadotropic hypogonadism, and have a desire to become pregnant.
Early Markers of Polycystic Ovary Syndrome (PCOS): Studies in Daughters of Women with PCOS – CLOSED FOR ENROLLMENT
Drs. Laura Torchen and Andrea Dunaif at Northwestern University in collaboration Dr. Christopher S. Sipe at FCI are performing studies in daughters of women with Polycystic Ovary Syndrome to look for early markers of PCOS risk.
Girls may be eligible to participate if they are aged 8-12 years and:
- Have no significant chronic medical problems
- Are not taking medications which may alter reproductive hormone levels
- Are not yet having menstrual periods
What participants may be asked to do:
- Answer questions regarding their medical history
- Have a brief physical exam by a study physician, including assessment of pubertal stage
- Have a fasting blood draw for measurement of hormones and collection of DNA
- Some participants may be eligible for additional studies or may be asked to return annually for a similar study visit
The initial study visit would be completed at Ann & Robert H Lurie Children’s Hospital of Chicago and would take 30-45 minutes to complete. Compensation is offered for participation. Your participation is strictly voluntary and confidential.
Institutional Review Board (IRB) #2006-12785, PCOS Registry – Child, Dr. Torchen. The content of this notice has been approved by the IRB.
Fertility Preservation Decision Support Aid for Young Women with Cancer: An Intervention Development Pilot Study – CLOSED FOR ENROLLMENT
Dr. Jennifer Hirshfeld-Cytron and Fertility Centers of Illinois are collaborating with the University of Illinois at Chicago to learn whether a new educational computer program can help young women with cancer in making fertility preservation treatment decisions. In addition, the researchers want to learn more about how this newly developed computer program can best help young women make this choice.
You may be eligible to participate in this innovative study if you are Between 18 to 42 years of age and:
- Diagnosed with cancer
- Able to speak English
- Eligible for egg, embryo, or ovarian tissue preservation (freezing)
- Willing and able to talk or write about questions related to the decision support computer program
What you will be asked to do:
- Answer a few brief questions by phone to screen for your eligibility
- Complete several questionnaires about your knowledge of fertility preservation and the decision-making process
- Complete one of two computer programs for which you will be assigned and the accompanying workbook
- Answer several questionnaires after you complete the computer program including a few questions about your background such as your age and occupation
- Complete an interview by phone or email to answer questions about how we might improve the computer program
It will take about 2 hours to 2 hours and 30 minutes of your time to complete the entire study depending on how much time you take to answer questions, view the computer program, and talk or write about the computer program. Your participation in this research is strictly voluntary and confidential. Click Here for more information
Joint Research Study To Find Out Whether Yoga Can Help Your Fertility – CLOSED FOR ENROLLMENT
Fertility Centers of Illinois and Pulling Down the Moon are conducting a joint research study to learn whether yoga has an impact on anxiety levels and pregnancy outcomes in women going through medicated fertility cycles. The Lead Investigators on this study are Jennifer Hirshfeld-Cytron, MD of Fertility Centers of Illinois and Beth Heller, MS of Pulling Down the Moon.
Study participants will attend a six-week Yoga for Fertility program for half price at Pulling Down the Moon (a $105 savings!). Women not interested in yoga, but eager to help explore the relationship between anxiety and fertility, will also be able to take part. Yoga classes will be held in Chicago – River North and Highland Park.
- Please print, read, and sign this Consent Form. This form is to be returned to the Fertility Centers of Illinois administration desk.
- Log on to Mind Garden and fill out the initial research questionnaire. The questionnaire should take about 10 minutes to complete.
- If you wish to participate in the yoga portion of the study, after filling out the online anxiety questionnaire (link above) you can contact Pulling Down the Moon at (312) 321-0004 to register for your class at the discounted rate of $110.
- All participants (yoga and no-yoga) will complete a follow up anxiety questionnaire 6-8 weeks after the initial questionnaire was completed.
For information about participation you can email: Beth Heller, MS.
Infertility Study For Women Age 35-42 Undergoing IVF – CLOSED FOR ENROLLMENT
This study is testing a new follicle stimulating hormone (FSH) treatment called AFOLIA comparing it to the US approved Gonal-F. FSH helps healthy ovaries to make eggs in women.
Each patient in this study would be participating for approximately 14 weeks per cycle, similar to the amount of time spent in a regular IVF cycle. This study requires frequent visits to the doctor’s office involving procedure such as having blood drawn, pelvic ultrasounds, self-injected medications and egg retrieval to remove eggs for embryo-transfer. Each patient may be eligible to complete up to 3 IVF cycles.
The study drug is free of charge for all participants and the IVF procedure is offered at a lower cost than other options.
If you are between 35 and 42 years of age with presence of both ovaries, you may qualify for this medical research program.
To qualify you must:
- Be trying to conceive
- Be clinically in good health
- Have regular menstrual cycles
- Have been told that you need in vitro fertilization (IVF) to conceive
The MultiCenter Registry with Eeva™ (MERGE) Research Study – CLOSED FOR ENROLLMENT
The MultiCenter Registry with Eeva™ (MERGE) Research Study is currently recruiting patients at Fertility Centers of Illinois.
Eeva: The Early Embryo Viability Assessment Test, is a test to be used by IVF laboratories to analyze early embryo development and to aid in the selection of the best embryo for transfer. At the heart of Eeva is software that was designed to assess critical differences in early embryo growth and determine an embryo’s viability and the potential for further development.
The Eeva Test was developed based on landmark research conducted at Stanford University1 which discovered that early embryo growth events can predict embryo development and reflect the underlying health of the embryo.
Auxogyn Inc. recently completed a multi-center clinical trial using Eeva with 54 patients and 758 embryos. The results from the trial supported that when embryologists used Eeva in conjunction with their traditional techniques they were able to correctly identify non-viable embryos 86% of the time vs. only 58% of the time without using Eeva2.
The goal of the MERGE study is to record and evaluate the use of traditional embryo grading techniques combined with Eeva in the treatment of in vitro fertilization.
To learn more about the study and determine whether you may be eligible to participate in the study, please contact Sue Jasulaitis, R.N. at (847) 916-6297 or by email. Eeva is an Investigational device. Limited by United States law to investigational use.
1. Wong et al. in Nature Biotechnology, 2010.
2. Conaghan et al. Fertility &Sterility, May 2013